News

Public · Published

Barclays maintains Harmonic at Equal-Weight, lowers price target to $14 from $16

Barclays kept its Equal-Weight rating on Harmonic and cut its price target to $14 from $16, a 12.5% decrease. The new target implies 37.4% upside from the November 2 close of $10.19.

Published:

Updated:

What happened

Barclays kept its Equal-Weight rating on Harmonic and cut its price target to $14 from $16, a 12.5% decrease. The new target implies 37.4% upside from the November 2 close of $10.19.

Confirmed

Global impact / market context

A lower price target signals the analyst expects less upside in Harmonic's shares than before, even while keeping a neutral Equal-Weight rating that means neither buy nor sell. Long-term holders get a reduced but still positive expected return benchmark to weigh against their own view.

Analyst inference

The target implies 37.4% upside from the $10.19 close, so Barclays still sees meaningful gains ahead despite the cut. The unchanged Equal-Weight rating suggests the revision reflects softer assumptions, not a changed stance on the stock's risk or outlook.

Analyst inference

What to watch

  1. Barclays lowered its Harmonic price target to $14 from $16, a 12.5% decrease, while keeping an Equal-Weight rating on the stock. Confirmed
  2. Watch whether other analysts also cut their Harmonic targets, which would suggest broader lower expectations for the company's future profit and revenue. Analyst inference
  3. Track Harmonic's next results for weaker revenue or higher costs, since that would support the lower target and could shift the neutral rating. Analyst inference

Evidence

  • Original source link unavailable